Why the study?
Does alcohol septal ablation improve clinical and echocardiographic outcomes in patients with hypertrophic obstructive cardiomyopathy?
Population
2,959 patients with hypertrophic obstructive cardiomyopathy from 42 published studies, mean age 53.5 years…
Design
Systematic_review
Follow-up
mean 12.7 +/- 0.3 months
Authors
Loading...
Supports ASA for symptomatic obstructive HCM; confirms 12-month gradient and symptom benefits with low mortality but notable pacemaker risk.
Does alcohol septal ablation improve clinical and echocardiographic outcomes in patients with hypertrophic obstructive cardiomyopathy?
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy provides favorable acute and intermediate-term clinical and echocardiographic outcomes, though it carries a notable risk of complete heart block requiring a pacemaker.
Alam et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: